TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.500
+0.160 (6.84%)
At close: May 22, 2026, 4:00 PM EDT
2.453
-0.047 (-1.87%)
After-hours: May 22, 2026, 7:54 PM EDT

TuHURA Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jun '23 Jun '22
Selling, General & Admin
7.457.583.874.14--
Research & Development
21.1820.5313.3425.62--
Other Operating Expenses
-3.680.44---
Total Operating Expenses
28.6331.817.6529.7600
Operating Income
-32.31-31.8-17.65-29.76--
Interest Income
-0.06-0.14-0.36-0.09--
Interest Expense
-0.65-0.63-4.14-0.02--
Other Non-Operating Income (Expense)
0.940.58-0.37-0.38--
Total Non-Operating Income (Expense)
0.23-0.18-4.87-0.49--
Pretax Income
-32.07-31.98-22.52-30.25--
Net Income
-30.93-30.06-22.65-29.32-15.02-25.13
Net Income Attributable to Preferred Dividends
-0.01-0.01-0.97--0.37-2.47
Net Income to Common
-30.93-30.06-22.65-29.32-15.02-25.13
Shares Outstanding (Basic)
544819100
Shares Outstanding (Diluted)
544819100
Shares Change (YoY)
103.28%156.81%2378.73%1526.67%33.06%56.78%
EPS (Basic)
-0.58-0.63-1.21-2.47-324.45-722.40
EPS (Diluted)
-0.58-0.63-1.21-2.47-324.45-722.40
Shares Outstanding
63.5859.3412.170.360.060.06
Free Cash Flow
-27.39-27.71-14.79-12.03-12.1-20.39
Free Cash Flow Per Share
-0.65-0.58-0.79-15.98-261.36-586.22
EBITDA
-32.23-31.72-17.53-29.593.290.06
EBIT
-32.31-31.8-17.65-29.76--
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q